Night sweats, teeth grinding, and erectile dysfunction. These might seem like minor or unrelated quirks, but they can all be symptoms of Obstructive Sleep Apnea, a silent health crisis affecting over 1 billion people worldwide. Vivos Therapeutics is at the forefront of addressing this issue, helping clinicians identify these “hidden signs” early and provide innovative, […]
BrightNight, the next-generation power and digital infrastructure company built to deliver clean and dispatchable solutions, today announced the appointment of Scott Bolton as Senior Vice President of External Affairs. https://mma.prnewswire.com/media/1978189/BrightNight_Logo.jpg Scott will lead BrightNight's public policy, regulatory, and strategic communications in support of market expansion and asset development. Scott brings more than 25 years of
Where Food Comes From, Inc. Reports 2025 Second Quarter Financial Results GlobeNewswire August 07, 2025 Second Quarter Highlights – 2025 vs. 2024 Verification and certification revenue: $5.33M vs. $5.25M Product sales: $964,000 vs. $819,000 Total revenue: $6.6M vs. $6.4M Net income: $562,000 vs. $489,000 Diluted EPS: $0.11 vs. $0.09 Stock buybacks: 24,481 shares Six Month
Vetster Named “Pet App of the Year” in 2025 Pet Innovation Awards Annual Awards Program Recognizes Companies, Services And Products Within The Rapidly Expanding Pet Industry That Exemplify Excellence & Innovation GlobeNewswire August 07, 2025 LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — Millions of pet parents face delays, unexpected costs, and the stress of
LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) — The 2025 Pet Innovation Awards today announced that Crumps' Naturals, from the Crump Group, a family-run, Canadian company producing naturally made, single or limited ingredient dog treats since 2006, has been awarded “Dog Treat Health-based Product of the Year” for their Gutsy line of products. The Pet
First and Only Liquid Embolic Approved for Hypervascular Tumor Embolization Supported by a Prospective, Randomized, Controlled, Clinical Trial Instylla, Inc., a privately held company developing novel resorbable embolics for peripheral vascular embolization, announced premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for the company's flagship product Embrace™ Hydrogel Embolic System. Embrace HES
From giant showstopper items and aDía de los Muertos limited-run capsule collection, to plush pumpkin lattes and vampire beds, Petco's seasonal drop brings joy to every kind of pet with more on-trend newness than ever before Petco is kicking off spooky season with the return of its fan-favorite Halloween “Bootique”and cozy fall collections, offering over
IRVINE, CA / ACCESS Newswire / August 7, 2025 / Netlist, Inc. (OTCQB:NLST) today reported financial results for the second quarter ended June 28, 2025. Recent Highlights: Revenue for the second quarter of 2025 increased by 44%, or $12.7 million, compared to the first quarter of 2025. Operating expenses for the second quarter of 2025
DALTON, GA / ACCESS Newswire / August 7, 2025 / The Dixie Group, Inc. (OTCQB:DXYN) today reported financial results for the quarter ended June 28, 2025. The gross profit margin for the second quarter of 2025 was 29.2% of net sales compared to 28.1% in the second quarter of 2024 Operating income in the second
ALBANY COUNTY, WY / ACCESS Newswire / August 7, 2025 / Buyer Group International, Inc. (OTCID:BYRG) is pleased to announce significant permitting progress for its New Rambler Re-dig Project at the Shambhala #71 claim location. This Copper-Platinum Group Metals (PGM) Project, located in Albany County, Wyoming has now secured key approvals from multiple regulatory agencies